Healthcare Industry News:  Cerner 

Biopharmaceuticals Drug Delivery

 News Release - March 11, 2008

Cerner and UNMHSC Sign Agreement to Evaluate Dry-Powder Inhaler Drug-Delivery Technology

Research Could Potentially Result in Better Outcomes for People Living with Asthma and Chronic Obstructive Lung Disease

KANSAS CITY, Mo. & ALBUQUERQUE, N.M.--(HSMN NewsFeed)--Cerner Corporation (NASDAQ: CERN ), the University of New Mexico Health Sciences Center (UNMHSC) College of Pharmacy, the UNM School of Engineering and STC.UNM (STC), the University’s technology-transfer corporation, announced today the signing of a Sponsored Research Agreement to evaluate UNMHSC’s dry-powder inhaler (DPI) drug-delivery technology for use in both pulmonary and systemic conditions, like asthma and chronic obstructive lung disease. Upon completion of the research studies, the agreement provides Cerner an option for exclusive licensing of UNMHSC’s technology for clinical and commercial use worldwide.

Cerner’s depth of research experience and proven ability to connect retrospective information with real-time point of care makes a difference for people living with chronic disease every day. This Sponsored Research Agreement is a clear opportunity for Cerner and UNMHSC to make a difference for people who could benefit from this new type of inhaler technology.

“Based upon its impressive capabilities for dispersal of particles with only small inspiratory effort, we believe UNMHSC’s DPI technology can become an important addition to the therapeutic armamentarium, especially for indications that affect children and the elderly,” said Douglas McNair, M.D., Ph.D., Cerner Senior Vice President for Clinical Research. “We believe UNMHSC’s technology can contribute significantly in addressing higher morbidity populations and indications than presently available inhaler devices. Cerner identified the gaps in existing systemic therapeutics and the incomplete coverage by pulmonary delivery modalities by data mining of de-identified clinical data sources.”

“We are extremely pleased to be working with Cerner to advance the state-of-the-art in drug-delivery by the pulmonary route,” said Hugh Smyth, Ph.D., UNMHSC Assistant Professor, Division of Pharmaceutical Sciences at the College of Pharmacy. “Bench-testing and initial human studies of our aeroelastic dispersion technology have shown promise, and suggest that it is capable of producing consistent deposition in the deep lung. The comparatively low pressure gradient required should enable this device to address various important unmet needs, not just in ambulatory patients with chronic conditions but in certain in-patient acute-care indications as well.”

Elizabeth Kuuttila, STC.UNM President and CEO, said, “Cerner’s readiness to partner with the University validates both the enablement of our DPI drug-delivery technology platform and their leadership as an informatics-based life sciences development company.”

Cerner is the leading healthcare information technology company in the discovery of clinical opportunities from data and closing the loop through process optimization, healthcare device development including the CareAware RxStation™ medication administration devices, and drug and drug delivery technologies. Financial terms of the agreement were not disclosed.

About STC.UNM

STC.UNM is a nonprofit corporation formed and owned entirely by the UNM Regents. The mission of STC is to support UNM and its partners as the source for innovation management and commercial development. STC does this by connecting the business community to UNM; protecting and transferring intellectual property and faculty inventions to the commercial marketplace; and by assisting companies and organizations that wish to access facilities, expertise, and research conducted at UNM. As STC has evolved, the corporation not only assists UNM faculty, but students, outside inventors, and entrepreneurs alike. www.stc.unm.edu

About UNMHSC College of Pharmacy

The College of Pharmacy at the University of New Mexico was founded in 1945 as the first health professional college in New Mexico and has graduated over 2,500 pharmacists since 1949. Approximately 70 percent of all practicing pharmacists in New Mexico are UNM alumni (1000/1500). The College enrolls the most ethnically diverse student body of any school of pharmacy in the U.S. and enrolls the second highest percentage of Hispanic and Native American student pharmacists of any U.S. pharmacy school. The College was ranked 46th by the US News and World Report in 2005 and ranked 31st in NIH funding among pharmacy schools in 2007. The mission of the College of Pharmacy is to develop innovative leaders in pharmaceutical care and research who enhance the quality of life for the people of New Mexico and the United States. http://hsc.unm.edu/pharmacy

About UNM School of Engineering

Founded in 1906, the University of New Mexico School of Engineering offers engineering and computer science undergraduate and graduate degree programs in a research-intensive environment. The mission of the School of Engineering is to educate students in engineering and computer science to contribute to the social, technological, and economic development of our state, nation, and global community. The School offers a superior education in engineering and computer science in an environment that fosters teamwork, cultural and intellectual diversity, a strong sense of public responsibility, and lifelong learning. www.soe.unm.edu

About Cerner

Cerner is taking the paper chart out of healthcare, eliminating error, variance and waste in the care process. With more than 6,000 clients worldwide, Cerner is the leading supplier of healthcare information technology. The following are trademarks of Cerner: Cerner and Cerner’s logo. (NASDAQ: CERN ). www.Cerner.com



Source: Cerner Corp

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.